27.11.2015
To the attention of interested persons
The National Agency for Medicines and Medical Devices hereby informs on notification from the Marketing Authorisation Holder concerning restart of manufacturing of DIGOXIN ZENTIVA 0.25 mg tablets and DIGOXIN ZENTIVA 0.5 mg/2 ml solution for injection. According to the notification, the first batches have been released for distribution by the manufacturing unit starting with 26.11.2015.
Therefore, restart of the manufacturing process ends the period of temporary shortage of supply for these products.